{
    "nctId": "NCT06555692",
    "briefTitle": "Evaluation of the Clinical Effectiveness and Safety of Acellular Dermal Matrix(SC DERM\u00ae Recon) in Breast Reconstruction",
    "officialTitle": "After Mastectomy in Breast Cancer Patients, Prospective and Retrospective Study to Evaluate the Clinical Effectiveness and Safety of Supercritical Carbon Dioxide Processed Acellular Dermal Matrix(SC DERM\u00ae Recon) in Breast Reconstruction",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Female, Breast Reconstruction",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Assessment of Breasts by Independent Investigator Using a 5-Point Likert Scale",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patients aged 20 to 69 scheduled for total mastectomy\n* Patients who are willing to undergo immediate breast reconstruction using implants.\n\nExclusion Criteria:\n\n* Patients who have undergone organ transplantation and are currently taking immunosuppressive medication.\n* Patients with mental conditions that could impact the conduct of the clinical study, such as alcohol or drug abuse.\n* Patients who have participated in another clinical trial within 120 days prior to screening.\n* Any other cases where the investigator deems the patient unsuitable for this clinical study.",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}